体外受精（IVF）市场规模、份额和成长分析（按产品类型、产品类型、设备、最终用户和地区划分）－2026-2033年产业预测

预计到 2024 年，体外受精 (IVF) 市场规模将达到 290.5 亿美元，到 2025 年将成长至 314.9 亿美元，到 2033 年将成长至 600.4 亿美元，在预测期（2026-2033 年）内复合成长率为 8.4%。

全球体外受精（IVF）市场涵盖了体外受精这项辅助生殖技术，可在体外实现受精，并被广泛接受为不孕夫妇提供解决方案。其关键步骤包括卵巢刺激、取卵、受精和胚胎移植，这些步骤均针对自然受孕困难的患者量身定制。由于生活方式和健康问题导致全球不孕不育率不断上升，越来越多的夫妇选择体外受精来建立家庭。技术进步（包括改进的实验室技术和基因检测）提高了成功率，并吸引了更多寻求可靠治疗的患者。此外，发展中国家对体外受精的认识不断提高，为透过建立体外受精诊所来拓展市场提供了巨大的机会。持续的技术进步为不孕夫妇的求子之路带来了希望，帮助他们应对心理和生理上的挑战。

体外受精市场成长要素

体外受精（IVF）市场正经历显着成长，这主要得益于生殖技术的不断进步，这些进步改进了IVF流程。诸如延时成像系统等创新技术能够对胚胎发育进行持续监测，从而显着优化胚胎选择过程并提高成功率。这些技术突破不仅优化了受孕成功率，也吸引了越来越多寻求不孕症治疗的个人和夫妇。随着人们对这些先进技术的了解不断加深，越来越多的人选择IVF治疗，这进一步推动了市场需求，并支持对尖端生殖技术研发的持续投资。

体外受精市场的限制

试管婴儿治疗的高昂费用对许多寻求不孕症治疗的个人和夫妇来说构成了一大障碍。药物费用、检查费用以及可能需要多次治疗週期所带来的经济负担可能非常沉重。因此，对于那些资金不足或缺乏适当保险的人来说，试管婴儿治疗可能遥不可及。这种经济限制不仅使相当一部分人无法获得治疗，还会增加面临不孕症挑战者的压力和心理负担。消除这些经济障碍对于扩大试管婴儿治疗的覆盖范围至关重要。

体外受精市场趋势

体外受精（IVF）市场正经历基因检测技术，特别是胚胎着床前基因检测（PGT）的显着融合趋势。这一趋势反映出准父母对更先进的生殖健康方案的需求日益增长，旨在提高怀孕成功率并降低儿童遗传疾病的风险。随着夫妻寻求优化IVF结果，PGT及类似技术的应用预计将会扩大，从而推动创新并创造新的市场机会。这种对基因筛检日益增长的关注，与以个人化医疗和强化生殖健康解决方案为重点的更广泛的医疗保健倡议不谋而合。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析

全球体外受精（IVF）市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 新捐赠者
• 新鲜非捐赠者
• 冷冻捐赠者
• 冷冻非捐赠者

全球体外受精（IVF）市场规模（按产品和复合年增长率划分）（2026-2033 年）

• 装置
  • 精子分析系统
  • 影像系统
  • 卵子吸泵
  • 微型机械手臂系统
  • 培养箱
  • 气体分析仪
  • 雷射系统
  • 冷冻保存系统
  • 精子分离装置
  • 试管婴儿诊所
  • 隔振台
  • 观测系统
  • 其他设备
• 试剂和介质
  • 冷冻保存介质
  • 胚胎培养基
  • 卵子处理培养基
  • 精子处理培养基
• 配件

全球体外受精（IVF）市场规模（按类型和复合年增长率划分）（2026-2033 年）

• 传统体外受精
• 体外受精（IVF）合併卵胞浆内单一精子注射（ICSI）技术
• 利用捐赠卵子进行体外受精
• 其他的

全球体外受精（IVF）市场规模（依设备及复合年增长率划分）（2026-2033 年）

• 培养基
• 免洗设备
• 资本设备

全球体外受精（IVF）市场规模（依最终用户划分）及复合年增长率（2026-2033 年）

• 不孕不育诊所
• 手术中心
• 医院
• 研究所

全球体外受精（IVF）市场规模（依地区划分）及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• Ferring Pharmaceuticals（Switzerland）
• Merck KGaA（Germany）
• Cook Medical（USA）
• Vitrolife AB（Sweden）
• CooperSurgical, Inc.（USA）
• Ovascience, Inc.（USA）
• Irvine Scientific（USA）
• Genea Limited（Australia）
• Origio A/S（Denmark）
• Thermo Fisher Scientific Inc.（USA）
• Esco Medical ApS（Denmark）
• Nidacon International AB（Sweden）
• Boston IVF（USA）
• Virtus Health（Australia）
• Bloom Fertility Centre（India）
• Rainbow IVF（India）
• IVI RMA Global（Spain）
• CHA Healthcare（South Korea）
• Reproductive Medicine Associates of New Jersey（RMANJ）（USA）
• TSLC Corporation（Japan）

结论与建议

In Vitro Fertilization Market size was valued at USD 29.05 Billion in 2024 and is poised to grow from USD 31.49 Billion in 2025 to USD 60.04 Billion by 2033, growing at a CAGR of 8.4% during the forecast period (2026-2033).

The global In Vitro Fertilization (IVF) market encompasses assisted reproductive technology procedures that facilitate fertilization outside the human body, gaining widespread acceptance as a solution for couples experiencing infertility. Key procedures-ovarian stimulation, egg retrieval, fertilization, and embryo transfer-are tailored for individuals when natural conception is challenging. As global infertility rates rise due to lifestyle factors and health issues, couples increasingly turn to IVF for family building. Technological advancements, including improved laboratory techniques and genetic testing, enhance success rates, attracting more individuals seeking reliable treatments. Additionally, growing awareness in developing regions provides significant opportunities for market expansion through the establishment of IVF clinics. Continuous evolution in techniques offers hope for couples on their fertility journeys, addressing both emotional and physical challenges.

Top-down and bottom-up approaches were used to estimate and validate the size of the In Vitro Fertilization market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

In Vitro Fertilization Market Segments Analysis

Global In Vitro Fertilization Market is segmented by Product Type, Product, Type, Instrument, End User and region. Based on Product Type, the market is segmented into Fresh Donor, Fresh Non-Donor, Frozen Donor and Frozen Non-Donor. Based on Product, the market is segmented into Equipment, Reagents & Media and Accessories. Based on Type, the market is segmented into Conventional IVF, IVF with ICSI, IVF with Donar Eggs and Others. Based on Instrument, the market is segmented into Culture Media, Disposable Devices and Capital Equipment. Based on End User, the market is segmented into Fertility Clinics, Surgical Centers, Hospitals and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the In Vitro Fertilization Market

The In Vitro Fertilization market is experiencing substantial growth, fueled by ongoing advancements in reproductive technologies that enhance IVF procedures. Innovations such as time-lapse imaging systems facilitate continuous observation of embryo development, which significantly improves selection processes and increases success rates. These technological breakthroughs not only optimize the chances of successful pregnancies but also appeal to a growing number of individuals and couples seeking fertility solutions. As awareness of these advanced methods spreads, more people are opting for IVF treatments, further driving market demand and encouraging continued investment in the development of cutting-edge reproductive technologies.

Restraints in the In Vitro Fertilization Market

The high costs associated with In Vitro Fertilization treatments present a considerable barrier for many individuals and couples seeking fertility solutions. The financial burden stemming from medications, laboratory procedures, and the potential need for multiple treatment cycles can be overwhelming. As a result, IVF may become unattainable for those who lack sufficient financial resources or adequate insurance coverage. This economic constraint not only limits access for a significant segment of the population but may also lead to increased stress and emotional strain for those navigating the challenges of infertility. Addressing these financial obstacles is crucial for expanding access to IVF.

Market Trends of the In Vitro Fertilization Market

The In Vitro Fertilization market is experiencing a notable shift towards the integration of genetic testing techniques, particularly preimplantation genetic testing (PGT). This trend reflects an increasing demand among prospective parents for enhanced reproductive options aimed at improving the likelihood of successful pregnancies and minimizing the risk of genetic disorders in children. As couples seek to optimize their IVF outcomes, the adoption of PGT and similar technologies is expected to expand, driving innovation and creating new market opportunities. This growing emphasis on genetic screening aligns with broader healthcare initiatives focused on personalized medicine and enhanced reproductive health solutions.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis

Global In Vitro Fertilization Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Fresh Donor
• Fresh Non-Donor
• Frozen Donor
• Frozen Non-Donor

Global In Vitro Fertilization Market Size by Product & CAGR (2026-2033)

• Market Overview
• Equipment
  • Sperm Analyzer Systems
  • Imaging Systems
  • Ovum Aspiration Pumps
  • Micromanipulator Systems
  • Incubators
  • Gas Analyzers
  • Laser Systems
  • Cryosystems
  • Sperm Separation Devices
  • IVF Cabinets
  • Anti-vibration Tables
  • Witness Systems
  • Other Equipments
• Reagents & Media
  • Cryopreservation Media
  • Embryo Culture Media
  • Ovum Processing Media
  • Sperm Processing Media
• Accessories

Global In Vitro Fertilization Market Size by Type & CAGR (2026-2033)

• Market Overview
• Conventional IVF
• IVF with ICSI
• IVF with Donar Eggs
• Others

Global In Vitro Fertilization Market Size by Instrument & CAGR (2026-2033)

• Market Overview
• Culture Media
• Disposable Devices
• Capital Equipment

Global In Vitro Fertilization Market Size by End User & CAGR (2026-2033)

• Market Overview
• Fertility Clinics
• Surgical Centers
• Hospitals
• Research Institutes

Global In Vitro Fertilization Market Size & CAGR (2026-2033)

• North America (Product Type, Product, Type, Instrument, End User)
  • US
  • Canada
• Europe (Product Type, Product, Type, Instrument, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Product, Type, Instrument, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Product, Type, Instrument, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Product, Type, Instrument, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Ferring Pharmaceuticals (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vitrolife AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ovascience, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Irvine Scientific (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Genea Limited (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Origio A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esco Medical ApS (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nidacon International AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston IVF (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Virtus Health (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bloom Fertility Centre (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Rainbow IVF (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IVI RMA Global (Spain)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CHA Healthcare (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Reproductive Medicine Associates of New Jersey (RMANJ) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TSLC Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations